Results 151 to 160 of about 87,239 (208)

Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer

memo - Magazine of European Medical Oncology, 2020
In locally advanced rectal cancer, neoadjuvant chemoradiotherapy provides a significant benefit to local cancer control in addition to total mesorectal excision.
Fabian Lunger, Georgios Peros
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Chemoradiotherapy

Nihon Geka Gakkai zasshi, 2008
In Western countries, chemotherapy or chemoradiotherapy followed by surgery is the standard treatment and definitive chemoradiotherapy is also standard treatment option for localized advanced esophageal cancer. On the other hand, in Japan, only surgery is recognized as standard of care.
Marcel Verheij, Harry Bartelink
  +5 more sources

Concomitant chemoradiotherapy.

Journal of Clinical Oncology, 1990
The title of Table 4 in the review article "Concomitant Chemoradiotherapy: Rationale and Clinical Experience in Patients With Solid Tumors" by Vokes and Weichselbaum published in the May 1990 issue (J Clin Oncol 8:911–934, 1990) was incorrect. It should
Everett E. Vokes, Ralph R. Weichselbaum
openaire   +2 more sources

Chemoradiotherapy in Gastrointestinal Malignancies

Clinical Oncology, 2009
Over the past 30 years, significant advances have been made in the integration of radiation therapy and chemotherapy in the treatment of patients with localised gastrointestinal malignancies. The therapeutic goal of chemoradiotherapy is to enhance local control resulting in improved survival and outcome of these patients. To define the optimal sequence,
C G, Willett, B G, Czito
openaire   +2 more sources

Prodrugs in Genetic Chemoradiotherapy

Current Pharmaceutical Design, 2003
Improvements in the radiotherapeutic management of solid tumors through the concurrent use of gene therapy is a realistic possibility. Of the broad array of candidate genes that have been evaluated, those encoding prodrug-activating enzymes are particularly appealing since they directly complement ongoing clinical chemoradiation regimes.
Adam V, Patterson, Mark P, Saunders, Olga, Greco   +2 more
openaire   +2 more sources

Rationale for chemoradiotherapy

International Journal of Clinical Oncology, 2004
The rationale for combining chemotherapy (CT) and radiotherapy (RT) is based mainly on two ideas, one being spatial cooperation and the other the enhancement of radiation effects. Spatial cooperation is effective if CT is sufficiently active to eradicate subclinical metastases and if the primary local tumor is effectively treated by RT. In this regard,
openaire   +2 more sources

Chemoradiotherapy in gallbladder cancer

Journal of Surgical Oncology, 2006
AbstractGallbladder cancer (GC) is considered a rare disease associated with a poor prognosis. Unfortunately, the low number of cases makes the performance of trials addressing the role of adjuvant, neoadjuvant, and/or palliative therapy difficult. For a long time, the majority of trials were 5‐fluorouracil (5 FU)‐based, and results were uniformly poor.
Aretxabala, Xabier de, Roa, Juan Carlos, León, Jorge, Maluenda, Fernando, Roa, Iván, Berríos Flores, Marcela Paz, Hepp, Juan, Gallardo, Jorge, Córdova, Andrés   +8 more
openaire   +2 more sources

Chemoradiotherapy for gastrointestinal cancers

Current Oncology Reports, 2005
New combinations of chemotherapy with radiotherapy for gastrointestinal cancers are showing evidence that improved outcomes may result from toxicity profiles associated with "targeted" systemic radiosensitizing agents. These new agents are also clinically attractive owing to such factors as oral bioavailability and patient dosing schedules, making them
Tyvin A, Rich, Christopher, Crane, Joshua D, Lawson, Jerome, Landry   +3 more
openaire   +2 more sources

Pancreatic cancer chemoradiotherapy

Best Practice & Research Clinical Gastroenterology, 2016
Pancreatic cancer is the most lethal gastrointestinal tumour. Chemotherapy is the mainstay of therapy in the majority of the patients whereas resection is the only chance of cure but only possible in 15-20% of all patients. The integration of radiotherapy into multimodal treatment concepts is heavily investigated.
Brunner, Thomas, Seufferlein, Thomas
openaire   +3 more sources

Chemoradiotherapy for cervical cancer

European Journal of Cancer, 2002
Cervical cancer remains a major health problem worldwide, despite advances in screening. For patients with locally advanced stage disease, failure to obtain local-regional control usually results in death. In an effort to improve local-regional tumour control, neoadjuvant and concurrent chemoradiation has been tested.
openaire   +2 more sources